Their white paper states that they aim to control 70 percent of the projected $200 bln medical AI market, through their 'distributed open network' system of artificial neural networks, which can diagnose patients and prescribe the relevant treatments. Setting up these symbiotic relationships will involve medical institution laboratories with large datasets, looking to set up and train their own neural networks. According to their roadmap, by June 2018 "The Skychain infrastructure is fully built, and early participants connect to it: healthcare data providers, medical AI developers, and hospitals." They aim to be fully established by June 2019 and become "The leader in the medical AI market." Skychain claims their mission is to save 10 mln lives from error-related deaths within a decade.